Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Estimation of atrial fibrillation recency of onset and safety of cardioversion using NTproBNP levels in patients with unknown time of onset.
Deftereos S, Giannopoulos G, Kossyvakis C, Raisakis K, Kaoukis A, Aggeli C, Toli K, Theodorakis A, Panagopoulou V, Driva M, Mantas I, Pyrgakis V, Rentoukas I, Stefanadis C. Deftereos S, et al. Among authors: pyrgakis v. Heart. 2011 Jun;97(11):914-7. doi: 10.1136/hrt.2010.214742. Epub 2011 Feb 8. Heart. 2011. PMID: 21303795
NTproBNP: an important biomarker in cardiac diseases.
Panagopoulou V, Deftereos S, Kossyvakis C, Raisakis K, Giannopoulos G, Bouras G, Pyrgakis V, Cleman MW. Panagopoulou V, et al. Among authors: pyrgakis v. Curr Top Med Chem. 2013;13(2):82-94. doi: 10.2174/1568026611313020002. Curr Top Med Chem. 2013. PMID: 23470072 Review.
Association of post-cardioversion transcardiac concentration gradient of soluble tumor necrosis factor-related apoptosis-inducing ligand (sTRAIL) and inflammatory biomarkers to atrial fibrillation recurrence.
Deftereos S, Giannopoulos G, Kossyvakis C, Raisakis K, Angelidis C, Efremidis M, Panagopoulou V, Kaoukis A, Theodorakis A, Toli K, Zavitsanakis P, Mantas I, Pyrgakis V, Stefanadis C, Cleman MW. Deftereos S, et al. Among authors: pyrgakis v. Clin Biochem. 2013 Aug;46(12):1020-1025. doi: 10.1016/j.clinbiochem.2013.02.003. Epub 2013 Feb 24. Clin Biochem. 2013. PMID: 23481489
Effectiveness of moxonidine to reduce atrial fibrillation burden in hypertensive patients.
Deftereos S, Giannopoulos G, Kossyvakis C, Efremidis M, Panagopoulou V, Raisakis K, Kaoukis A, Karageorgiou S, Bouras G, Katsivas A, Pyrgakis V, Stefanadis C. Deftereos S, et al. Among authors: pyrgakis v. Am J Cardiol. 2013 Sep 1;112(5):684-7. doi: 10.1016/j.amjcard.2013.04.049. Epub 2013 May 29. Am J Cardiol. 2013. PMID: 23726175 Clinical Trial.
Effect of radiographic contrast media on markers of complement activation and apoptosis in patients with chronic coronary artery disease undergoing coronary angiography.
Deftereos S, Giannopoulos G, Kossyvakis C, Raisakis K, Kaoukis A, Driva M, Ntzouvara O, Panagopoulou V, Rentoukas I, Nikas DJ, Pyrgakis V, Alpert MA. Deftereos S, et al. Among authors: pyrgakis v. J Invasive Cardiol. 2009 Sep;21(9):473-7. J Invasive Cardiol. 2009. PMID: 19726822 Clinical Trial.
98 results